Prashanth Godrehal

Ayurgenomics Portal – Discover Your Prakriti & Scientific Deep-Dive
AYURGENOMICS
Ayurvedic Phenotypes & Genome-Wide Association

Discover Your Ayurgenomic Constitution (Prakriti)

Bridging 5,000-year-old Ayurvedic clinical phenotyping with high-throughput genomic sequencing, metabolic pathways, and precision medicine. Assess your unique constitutional profile (*Tridosha*), receive customized dietary/lifestyle protocols, and explore the landmark molecular research validating it.

15
Clinical Features
Vata
Kinetic & Signal Axis
Pitta
Metabolic & Thermal Axis
Kapha
Anabolic & Cohesive Axis
Section 1

Understanding VPK: Systems Biology in Ayurveda

Ayurvedic medicine categorizes human physiological variability into three primary constitutional forces called Doshas: Vata, Pitta, and Kapha. Your baseline combination at birth forms your Prakriti, an invariant genomic fingerprint that influences tissue metabolism, immunological responses, and disease vulnerabilities.

Kinetic Vector VATA

Movement, Signal Transduction & Neurogenesis

Governs bodily movements, impulse propagation, cell cycle arrest, and respiratory mechanics. Characterized by light, cold, dry, and swift properties.

Enriched Genes: FAS, KCNJ2, CDK pathways
Key Biomarker: Prolonged Prothrombin Time
Thermal Vector PITTA

Metabolism, Energy Flux & Inflammation

Controls enzymatic transformations, thermoregulation, digestion (*Agni*), and cellular respiration. Characterized by hot, sharp, and intense properties.

Enriched Genes: PGM1, CH25H, Cytokines (IL-1,6)
Key Biomarker: High RBC, Hemoglobin & PCV
Anabolic Vector KAPHA

Structure, Anabolism & Fluid Homeostasis

Maintains musculoskeletal integrity, cellular lubrication, tissue mass, and immunity. Characterized by heavy, slow, stable, and smooth properties.

Enriched Genes: EGLN1 (TT), APOE, HLA-DQB1
Key Biomarker: High Total Cholesterol & Triglycerides
Section 2

Interactive Prakriti Assessment Simulation

Complete this 15-parameter phenotypic assessment based on the standardized double-blind clinical criteria published by Prasher et al. Select the option that best reflects your lifetime baseline traits.

0 of 15 parameters selected
Section 3 (Supplemental Research)

Prasher et al. (2008) Deep Study Analysis

For clinicians, geneticists, and researchers seeking to inspect the empirical molecular foundation: explore the full assay architecture, biochemical markers, microarray gene expression datasets, and post-2008 findings.

Module 1

Clinical Phenotype Matrix & Tri-Dosha Biological Foundations

Module 2

Multi-Layer Screening Architecture & Cohort Selection

1 850 Volunteers

Initial Clinical Screening

Screened by 2 independent Ayurvedic clinicians (ages 18-40).

2 IGVC Genotyping

Genetic Homogeneity

Clustered against 24 reference populations via SNP arrays.

3 80% Concordance

Double-Blind Verification

Swapped candidates between clinicians + software scoring.

4 N = 96 Cohort

Assay Execution

33 biochemical parameters, cDNA 19Kv8 arrays & qPCR.

Module 3

Empirical Biochemical & Hematological Profiling

33 biochemical markers were measured across healthy subjects. Statistically significant variations ($p \le 0.05$) emerged between phenotypes despite all values staying within healthy clinical reference ranges.

Values normalized to mean relative scale
Module 4

Transcriptomic Architecture & Validated Gene Loci

Microarray analysis identified 159 DEGs in males and 92 in females. 53 core biological hub genes were uncovered, with 31% overlapping known complex disease susceptibility loci (OMIM/GAD).

Module 5

Post-2008 Breakthroughs & High-Altitude Genomics

Aggarwal et al. (2010, 2015) EGLN1 rs479200

EGLN1 & High-Altitude Hypoxia Susceptibility

The EGLN1 gene targets $HIF-1\alpha$ for degradation. The $TT$ genotype—causing baseline overexpression and altitude maladaptation—is significantly overrepresented in Kapha individuals and absent in native high-altitude Sherpas.

Clinical Insight: Provides a molecular mechanism for Kapha susceptibility to High-Altitude Pulmonary Edema (HAPE) and vascular thrombosis.
Govindaraj et al. PGM1 rs11208257

PGM1 & Metabolic Energy Flux (Agni)

PGM1 regulates glucose-1-phosphate to glucose-6-phosphate conversion. The missense variant rs11208257 exhibits high allele frequency polarization in Pitta cohorts.

Ayurvedic Alignment: Directly correlates with Pitta’s high metabolic rate (*Agni*), rapid carbohydrate processing, and elevated body temperature.
Module 6

Methodological Critique & Strategic Roadmap

Study Limitations (2008 Paper)

  • Cohort Size ($N=96$): Ideal for extreme phenotyping, but underpowered for subtle polygenic networks.
  • cDNA Sample Pooling: Pooling RNA (5 samples/pool) reduced biological noise but masked individual variances.
  • Sexual Dimorphism: Strong hormonal confounding (159 male DEGs vs 92 female DEGs with only 5 overlapping genes).

Future Precision Health Horizon

  • AI Digital Phenotyping: Combining questionnaire scoring with wearable sensor pulse analysis (*Nadi Pariksha*).
  • Single-Cell Multi-Omics: Mapping real-time transcriptomic shifts across gut microbiome dynamics.
  • Stratified Clinical Trials: Stratifying patient arms by *Prakriti* to optimize drug efficacy and prevent adverse reactions.

Ayurgenomics Discovery & Study Portal

Integrating Traditional Ayurvedic Phenotyping with Multi-Omic & Precision Medicine

Based on Prasher et al. (2008) Journal of Translational Medicine 6:48